CIQClass II
Diazo, Ast/Sgot
21 CFR 862.1100 / Clinical Chemistry
CIQ is the FDA product code for Diazo, Ast/Sgot, a class II device type, regulated under 21 CFR 862.1100. As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- CIQ
- Device name
- Diazo, Ast/Sgot
- Regulation
- 21 CFR 862.1100
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 7
- Ingested recalls
- 1
Clearances, product code CIQ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1982 | 2 |
| 1984 | 2 |
| 1986 | 2 |
| 1988 | 1 |
Applicants with the most clearances
Product code CIQ| Applicant | Clearances |
|---|---|
| Anco Medical Reagents & Assoc. | 1 |
| Livonia Diagnostics, Inc. | 1 |
| Medical Specialties Inc. | 1 |
| Omega Medical Electronics | 1 |
| Sterling Diagnostics, Inc. | 1 |
| Tech-Co, Inc. | 1 |
| Technostics Intl. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
